Form 4: OPKO HEALTH, INC. Sells Shares of GeneDx Holdings Corp.

OPKO HEALTH, INC. reports the sale of 88,839 shares of GeneDx Holdings Corp. Class A Common Stock at an average price of $33.5027.

Summary

• On July 31, 2024, OPKO HEALTH, INC. sold 88,839 shares of GeneDx Holdings Corp. Class A Common Stock.
• The shares were sold at a weighted average price of $33.5027.
• The sales occurred in multiple transactions with prices ranging from $33.00 to $34.21.
• Following the reported transaction, OPKO HEALTH, INC. beneficially owns 2,984,564 shares of GeneDx Holdings Corp.
• The reporting person has undertaken to provide full information regarding the number of shares purchased at each separate price within the specified range upon request.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about a share sale.

Industry Context

This Form 4 filing indicates a change in ownership of GeneDx Holdings Corp. shares by a significant shareholder, OPKO HEALTH, INC. Such filings are common and provide transparency into the trading activities of insiders and major stakeholders, which can influence investor sentiment.

Stakeholder Impact

• Shareholders may react to the news of OPKO HEALTH, INC.'s share sale, potentially impacting the stock price of GeneDx Holdings Corp.

Key Dates